CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Clinical trials for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CANCER TREATMENT-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood infusion aims to rescue cancer Patients' platelet counts
Disease control Recruiting nowThis study tests whether a single infusion of umbilical cord blood can safely raise platelet levels in cancer patients whose platelets have dropped due to chemotherapy or other cancer treatments. Researchers will enroll 25 people aged 12 to 65 and monitor their blood counts for 2…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug aims to fix Chemo's side effect: low platelets
Symptom relief Recruiting nowThis study tests a drug called QL0911 for people whose platelet levels drop too low due to cancer treatment. Low platelets can delay chemotherapy and cause bleeding risks. The trial will compare QL0911 to a placebo in 235 adults aged 18-75 to see if it safely raises platelet coun…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC